Preventing healthcare-acquired infections in cancer patients with febrile neutropenia in intensive care units: The role of granulocyte-colony stimulating factor prophylaxis

Intensive Crit Care Nurs. 2023 Oct:78:103466. doi: 10.1016/j.iccn.2023.103466. Epub 2023 Jun 23.

Authors

Stijn Blot¹, Jean-Francois Timsit², Jean-Ralph Zahar³

Affiliations

¹ Dept. of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium. Electronic address: stijn.blot@UGent.be.
² INSERM, IAME UMR 1137, University of Paris, France; Medical and Infectious Diseases ICU, Bichat-Claude Bernard Hospital, APHP, Paris, France.
³ NSERM, IAME UMR 1137, University of Paris, France; Microbiology, Infection Control Unit, GH Paris Seine Saint-Denis, APHP, Bobigny, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

Delivery of Health Care
Febrile Neutropenia* / complications
Febrile Neutropenia* / drug therapy
Granulocyte Colony-Stimulating Factor / therapeutic use
Granulocytes
Humans
Intensive Care Units
Neoplasms* / complications
Neoplasms* / drug therapy

Substances

Granulocyte Colony-Stimulating Factor